Hennion & Walsh Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Sell
33,574
-294
-0.9% -$8.92K 0.04% 507
2026
Q1
$1.15M Buy
33,868
+398
+1% +$11.3K 0.04% 471
2025
Q4
$911K Buy
33,470
+7,969
+31% +$280K 0.03% 542
2025
Q3
$1.02M Buy
25,501
+10,496
+70% +$395K 0.04% 506
2025
Q2
$499K Buy
+15,005
New +$455K 0.02% 672
2023
Q2
Sell
-22,525
Closed -$517K 798
2023
Q1
$517K Sell
22,525
-772
-3% -$20.5K 0.03% 498
2022
Q4
$654K Buy
23,297
+2,944
+14% +$83K 0.04% 436
2022
Q3
$576K Sell
20,353
-282
-1% -$7.56K 0.04% 453
2022
Q2
$457K Sell
20,635
-307
-1% -$6.93K 0.03% 508
2022
Q1
$610K Buy
20,942
+427
+2% +$13K 0.03% 471
2021
Q4
$674K Buy
20,515
+1,283
+7% +$51.6K 0.03% 464
2021
Q3
$888K Buy
19,232
+6,586
+52% +$318K 0.05% 375
2021
Q2
$697K Sell
12,646
-2,735
-18% -$153K 0.04% 444
2021
Q1
$794K Buy
+15,381
New +$762K 0.05% 410

Other funds holding AGIO